CRISPR screen reveals XPO1 as a therapeutic target strongly sensitizing to first and second line therapy in small cell lung cancer Meeting Abstract


Authors: Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J.; Offin, M.; Egger, J.; Bhanot, U.; Qiu, J.; De Stanchina, E.; Sen, T.; Poirier, J. T.; Rudin, C.
Abstract Title: CRISPR screen reveals XPO1 as a therapeutic target strongly sensitizing to first and second line therapy in small cell lung cancer
Meeting Title: 2021 World Conference on Lung Cancer
Keywords: therapy; sclc; chemoresistant
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 10 Suppl.
Meeting Dates: 2021 Sep 8-14
Meeting Location: Virtual event
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S938
Language: English
ACCESSION: WOS:000709606500195
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.08.196
Notes: Meeting Abstract: MA16.03 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Umeshkumar Kapaldev Bhanot
    93 Bhanot
  2. Charles Rudin
    489 Rudin
  3. Nisargbhai Sanjaykumar Shah
    29 Shah
  4. Joseph Minhow Chan
    48 Chan
  5. Juan   Qiu
    24 Qiu
  6. Viola   Allaj
    29 Allaj
  7. Michael David Offin
    170 Offin
  8. Shweta S Chavan
    34 Chavan
  9. Andrew Chow
    45 Chow
  10. Jacklynn V Egger
    68 Egger
  11. Triparna Sen
    56 Sen
  12. Fathema Zannath Uddin
    22 Uddin
  13. Yingqian Zhan
    36 Zhan
  14. Parvathy Manoj
    35 Manoj